Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:32133283

The Prognostic Significance of Metabolic Syndrome and a Related Six-lncRNA Signature in Esophageal Squamous Cell Carcinoma.

Yu Liu · Liyu Wang · Hengchang Liu · Chunxiang Li · Jie He

Frontiers in oncology · 2020 doi:10.3389/fonc.2020.00061

Paper

complete

Experiment

complete

Data

partial

Analysis

complete

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:32133283
kind
science-record
content_hash
sha256:74fdc39d9c4607b0b4c49b671916c346fc5ffed5a1726b8c13a0496bb32b8f8d
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T15:40:57Z
updated_at
2026-11-01T22:01:21Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
The Prognostic Significance of Metabolic Syndrome and a Related Six-lncRNA Signature in Esophageal Squamous Cell Carcinoma.
doi
10.3389/fonc.2020.00061
pmid
32133283
authors array · 5 items
[0]
Yu Liu
[1]
Liyu Wang
[2]
Hengchang Liu
[3]
Chunxiang Li
[4]
Jie He
journal
Frontiers in oncology
year
2020
abstract
Background: Metabolic syndrome (MetS) is associated with the development of esophageal squamous cell carcinoma (ESCC), and long non-coding RNAs (lncRNAs) are involved in a variety of mechanisms of MetS and tumor. This study will explore the prognostic effect of MetS and the associated lncRNA signature on ESCC. Methods: Our previous RNA-chip data (GSE53624, GSE53622) for 179 ESCC patients were reanalyzed according to MetS. The recurrence-free survival (RFS) was collected for these patients. The status of the MetS-related tumor microenvironment was analyzed with the CIBERSORT and ESTIMATE algorithms. A lncRNA signature was established with univariate and multivariate Cox proportional hazards regression (PHR) analysis and verified using the Kaplan-Meier survival curve analysis and time-dependent receiver operating characteristic (ROC) curves. A clinical predictive model was constructed based on multiple risk factors, evaluated using C-indexes and calibration curves, and verified using data from the GEO and TCGA databases. Results: The results showed that MetS was an independent risk factor for ESCC patients conferring low OS and RFS. Tumor microenvironment analysis indicated that patients with MetS have high stromal scores and M2 macrophage infiltration. A six-lncRNA signature was established by 60 ESCC patients randomly selected from GSE53624 and identified with an effective predictive ability in validation cohorts (59 patients from GSE53624 and 60 patients from GSE53622), subgroup analysis, and ESCC patients from TCGA. MetS and the six-lncRNA signature could be regarded as independent risk factors and enhanced predictive ability in the clinical predictive model. Conclusions: Our results indicated that MetS was associated with poor prognosis in ESCC patients, and the possible mechanism was related to changes in the tumor microenvironment. MetS and the six-lncRNA signature could also serve as independent risk factors with available clinical application value.
claims array · 2 items
[0] object · 6 fields
id
claim-method
statement
Next, weighted gene co-expression network analysis (WGCNA) was also used to determine the relationship between the module gene and MetS. Significantly correlated module genes were selected using univariate Cox proportional hazards regression (PHR) analysis to calculate the correlation with OS and RFS. The identified lncRNAs with |z| > 2 were selected, and then, multivariate stepwise Cox PHR analysis was used to build a lncRNA predicting model and identify the best risk score cutoff value to distinguish ESCC patients.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:32133283
locator
sections[6] "Identification of lncRNA Signature to Predict the Prognosis for ESCC Patients" paragraph 2
quote
Next, weighted gene co-expression network analysis (WGCNA) was also used to determine the relationship between the module gene and MetS. Significantly correlated module genes were selected using univariate Cox proportional hazards regression (PHR) analysis to calculate the correlation with OS and RFS. The identified lncRNAs with |z| > 2 were selected, and then, multivariate stepwise Cox PHR analysis was used to build a lncRNA predicting model and identify the best risk score cutoff value to distinguish ESCC patients.
state
complete
[1] object · 6 fields
id
claim-data-access
statement
The data that support the findings of this study come from the public free-charged database, and the new clinical information will be available from the corresponding author, without undue reservation, to any qualified researcher.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:32133283
locator
sections[19] "Data Availability Statement" paragraph 2
quote
The data that support the findings of this study come from the public free-charged database, and the new clinical information will be available from the corresponding author, without undue reservation, to any qualified researcher.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
complete
objective
null
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:32133283
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE53622
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE53622
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 0 items
data object · 3 fields
state
partial
assets array · 7 items
[0] object · 15 fields
id
source:pmid:32133283
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.3389/fonc.2020.00061
sha256
sha256:df402d6c0ea0b65d233316e4608f1e59c9a0de6d52c65262536869057abf5567
bytes
29836
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.3389/fonc.2020.00061
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC7040247
source
europe_pmc_fulltext
coverage
whole_body_without_references
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:GSE53622
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE53622
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE53622
version
null
note
The data that support the findings of this study come from the public free-charged database, and the new clinical information will be available from the corresponding author, without undue reservation, to any qualified researcher.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
The data that support the findings of this study come from the public free-charged database, and the new clinical information will be available from the corresponding author, without undue reservation, to any qualified researcher.
access_statement_kind
data_availability_statement
sample_accessions array · 120 items
[0]
GSM1296956
[1]
GSM1296957
[2]
GSM1296958
[3]
GSM1296959
[4]
GSM1296960
[5]
GSM1296961
[6]
GSM1296962
[7]
GSM1296963
[8]
GSM1296964
[9]
GSM1296965
[10]
GSM1296966
[11]
GSM1296967
[12]
GSM1296968
[13]
GSM1296969
[14]
GSM1296970
[15]
GSM1296971
[16]
GSM1296972
[17]
GSM1296973
[18]
GSM1296974
[19]
GSM1296975
[20]
GSM1296976
[21]
GSM1296977
[22]
GSM1296978
[23]
GSM1296979
[24]
GSM1296980
[25]
GSM1296981
[26]
GSM1296982
[27]
GSM1296983
[28]
GSM1296984
[29]
GSM1296985
[30]
GSM1296986
[31]
GSM1296987
[32]
GSM1296988
[33]
GSM1296989
[34]
GSM1296990
[35]
GSM1296991
[36]
GSM1296992
[37]
GSM1296993
[38]
GSM1296994
[39]
GSM1296995
[40]
GSM1296996
[41]
GSM1296997
[42]
GSM1296998
[43]
GSM1296999
[44]
GSM1297000
[45]
GSM1297001
[46]
GSM1297002
[47]
GSM1297003
[48]
GSM1297004
[49]
GSM1297005
[50]
GSM1297006
[51]
GSM1297007
[52]
GSM1297008
[53]
GSM1297009
[54]
GSM1297010
[55]
GSM1297011
[56]
GSM1297012
[57]
GSM1297013
[58]
GSM1297014
[59]
GSM1297015
[60]
GSM1297016
[61]
GSM1297017
[62]
GSM1297018
[63]
GSM1297019
[64]
GSM1297020
[65]
GSM1297021
[66]
GSM1297022
[67]
GSM1297023
[68]
GSM1297024
[69]
GSM1297025
[70]
GSM1297026
[71]
GSM1297027
[72]
GSM1297028
[73]
GSM1297029
[74]
GSM1297030
[75]
GSM1297031
[76]
GSM1297032
[77]
GSM1297033
[78]
GSM1297034
[79]
GSM1297035
[80]
GSM1297036
[81]
GSM1297037
[82]
GSM1297038
[83]
GSM1297039
[84]
GSM1297040
[85]
GSM1297041
[86]
GSM1297042
[87]
GSM1297043
[88]
GSM1297044
[89]
GSM1297045
[90]
GSM1297046
[91]
GSM1297047
[92]
GSM1297048
[93]
GSM1297049
[94]
GSM1297050
[95]
GSM1297051
[96]
GSM1297052
[97]
GSM1297053
[98]
GSM1297054
[99]
GSM1297055
[100]
GSM1297056
[101]
GSM1297057
[102]
GSM1297058
[103]
GSM1297059
[104]
GSM1297060
[105]
GSM1297061
[106]
GSM1297062
[107]
GSM1297063
[108]
GSM1297064
[109]
GSM1297065
[110]
GSM1297066
[111]
GSM1297067
[112]
GSM1297068
[113]
GSM1297069
[114]
GSM1297070
[115]
GSM1297071
[116]
GSM1297072
[117]
GSM1297073
[118]
GSM1297074
[119]
GSM1297075
sample_count
120
group_sizes
null
group_sizes_basis
null
platform
18109
taxon
Homo sapiens
title
LncRNA profile study reveals a three-lncRNA signature associated with the survival of esophageal squamous cell carcinoma patients (independent set)
resolution_checked_at
2026-11-01T15:39:54Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[2] object · 15 fields
id
data:geo:GSE53624
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE53624
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE53624
version
null
note
The data that support the findings of this study come from the public free-charged database, and the new clinical information will be available from the corresponding author, without undue reservation, to any qualified researcher.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
The data that support the findings of this study come from the public free-charged database, and the new clinical information will be available from the corresponding author, without undue reservation, to any qualified researcher.
access_statement_kind
data_availability_statement
sample_accessions array · 238 items
[0]
GSM1297076
[1]
GSM1297077
[2]
GSM1297078
[3]
GSM1297079
[4]
GSM1297080
[5]
GSM1297081
[6]
GSM1297082
[7]
GSM1297083
[8]
GSM1297084
[9]
GSM1297085
[10]
GSM1297086
[11]
GSM1297087
[12]
GSM1297088
[13]
GSM1297089
[14]
GSM1297090
[15]
GSM1297091
[16]
GSM1297092
[17]
GSM1297093
[18]
GSM1297094
[19]
GSM1297095
[20]
GSM1297096
[21]
GSM1297097
[22]
GSM1297098
[23]
GSM1297099
[24]
GSM1297100
[25]
GSM1297101
[26]
GSM1297102
[27]
GSM1297103
[28]
GSM1297104
[29]
GSM1297105
[30]
GSM1297106
[31]
GSM1297107
[32]
GSM1297108
[33]
GSM1297109
[34]
GSM1297110
[35]
GSM1297111
[36]
GSM1297112
[37]
GSM1297113
[38]
GSM1297114
[39]
GSM1297115
[40]
GSM1297116
[41]
GSM1297117
[42]
GSM1297118
[43]
GSM1297119
[44]
GSM1297120
[45]
GSM1297121
[46]
GSM1297122
[47]
GSM1297123
[48]
GSM1297124
[49]
GSM1297125
[50]
GSM1297126
[51]
GSM1297127
[52]
GSM1297128
[53]
GSM1297129
[54]
GSM1297130
[55]
GSM1297131
[56]
GSM1297132
[57]
GSM1297133
[58]
GSM1297134
[59]
GSM1297135
[60]
GSM1297136
[61]
GSM1297137
[62]
GSM1297138
[63]
GSM1297139
[64]
GSM1297140
[65]
GSM1297141
[66]
GSM1297142
[67]
GSM1297143
[68]
GSM1297144
[69]
GSM1297145
[70]
GSM1297146
[71]
GSM1297147
[72]
GSM1297148
[73]
GSM1297149
[74]
GSM1297150
[75]
GSM1297151
[76]
GSM1297152
[77]
GSM1297153
[78]
GSM1297154
[79]
GSM1297155
[80]
GSM1297156
[81]
GSM1297157
[82]
GSM1297158
[83]
GSM1297159
[84]
GSM1297160
[85]
GSM1297161
[86]
GSM1297162
[87]
GSM1297163
[88]
GSM1297164
[89]
GSM1297165
[90]
GSM1297166
[91]
GSM1297167
[92]
GSM1297168
[93]
GSM1297169
[94]
GSM1297170
[95]
GSM1297171
[96]
GSM1297172
[97]
GSM1297173
[98]
GSM1297174
[99]
GSM1297175
[100]
GSM1297176
[101]
GSM1297177
[102]
GSM1297178
[103]
GSM1297179
[104]
GSM1297180
[105]
GSM1297181
[106]
GSM1297182
[107]
GSM1297183
[108]
GSM1297184
[109]
GSM1297185
[110]
GSM1297186
[111]
GSM1297187
[112]
GSM1297188
[113]
GSM1297189
[114]
GSM1297190
[115]
GSM1297191
[116]
GSM1297192
[117]
GSM1297193
[118]
GSM1297194
[119]
GSM1297195
[120]
GSM1297196
[121]
GSM1297197
[122]
GSM1297198
[123]
GSM1297199
[124]
GSM1297200
[125]
GSM1297201
[126]
GSM1297202
[127]
GSM1297203
[128]
GSM1297204
[129]
GSM1297205
[130]
GSM1297206
[131]
GSM1297207
[132]
GSM1297208
[133]
GSM1297209
[134]
GSM1297210
[135]
GSM1297211
[136]
GSM1297212
[137]
GSM1297213
[138]
GSM1297214
[139]
GSM1297215
[140]
GSM1297216
[141]
GSM1297217
[142]
GSM1297218
[143]
GSM1297219
[144]
GSM1297220
[145]
GSM1297221
[146]
GSM1297222
[147]
GSM1297223
[148]
GSM1297224
[149]
GSM1297225
[150]
GSM1297226
[151]
GSM1297227
[152]
GSM1297228
[153]
GSM1297229
[154]
GSM1297230
[155]
GSM1297231
[156]
GSM1297232
[157]
GSM1297233
[158]
GSM1297234
[159]
GSM1297235
[160]
GSM1297236
[161]
GSM1297237
[162]
GSM1297238
[163]
GSM1297239
[164]
GSM1297240
[165]
GSM1297241
[166]
GSM1297242
[167]
GSM1297243
[168]
GSM1297244
[169]
GSM1297245
[170]
GSM1297246
[171]
GSM1297247
[172]
GSM1297248
[173]
GSM1297249
[174]
GSM1297250
[175]
GSM1297251
[176]
GSM1297252
[177]
GSM1297253
[178]
GSM1297254
[179]
GSM1297255
[180]
GSM1297256
[181]
GSM1297257
[182]
GSM1297258
[183]
GSM1297259
[184]
GSM1297260
[185]
GSM1297261
[186]
GSM1297262
[187]
GSM1297263
[188]
GSM1297264
[189]
GSM1297265
[190]
GSM1297266
[191]
GSM1297267
[192]
GSM1297268
[193]
GSM1297269
[194]
GSM1297270
[195]
GSM1297271
[196]
GSM1297272
[197]
GSM1297273
[198]
GSM1297274
[199]
GSM1297275
[200]
GSM1297276
[201]
GSM1297277
[202]
GSM1297278
[203]
GSM1297279
[204]
GSM1297280
[205]
GSM1297281
[206]
GSM1297282
[207]
GSM1297283
[208]
GSM1297284
[209]
GSM1297285
[210]
GSM1297286
[211]
GSM1297287
[212]
GSM1297288
[213]
GSM1297289
[214]
GSM1297290
[215]
GSM1297291
[216]
GSM1297292
[217]
GSM1297293
[218]
GSM1297294
[219]
GSM1297295
[220]
GSM1297296
[221]
GSM1297297
[222]
GSM1297298
[223]
GSM1297299
[224]
GSM1297300
[225]
GSM1297301
[226]
GSM1297302
[227]
GSM1297303
[228]
GSM1297304
[229]
GSM1297305
[230]
GSM1297306
[231]
GSM1297307
[232]
GSM1297308
[233]
GSM1297309
[234]
GSM1297310
[235]
GSM1297311
[236]
GSM1297312
[237]
GSM1297313
sample_count
238
group_sizes
null
group_sizes_basis
null
platform
18109
taxon
Homo sapiens
title
LncRNA profile study reveals a three-lncRNA signature associated with the survival of esophageal squamous cell carcinoma patients (original)
resolution_checked_at
2026-11-01T15:39:54Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[3] object · 16 fields
id
asset:table:pmid:32133283:1
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:5c52ee8850452a4f72cab24a45a9c8c9a7cac2a4efc93292f3f45bc0ab484658
bytes
2406
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[12]/table-wrap[1]#T1
version
null
note
The clinical characteristics at baseline, stratified by metabolic syndrome (MetS).
structure object · 5 fields
pmcid
PMC7040247
section_index
12
section_title
Mets Is an Independent Prognostic Factor for ESCC
row_count
59
column_count
4
table object · 8 fields
label
Table 1
caption
The clinical characteristics at baseline, stratified by metabolic syndrome (MetS).
rows array · 59 items
[0] array · 4 items
[0]
Variable
[1]
Without MetS
[2]
With MetS
[3]
p value
[1] array · 4 items
[0]
No. of patients
[1]
153
[2]
26
[3]
[2] array · 4 items
[0]
Age
[1]
[2]
[3]
0.061
[3] array · 4 items
[0]
<50
[1]
21 (13.73%)
[2]
2 (7.69%)
[3]
[4] array · 4 items
[0]
50–59
[1]
60 (39.22%)
[2]
6 (23.08%)
[3]
[5] array · 4 items
[0]
60–69
[1]
58 (37.91%)
[2]
12 (46.15%)
[3]
[6] array · 4 items
[0]
70–79
[1]
11 (7.19%)
[2]
6 (23.08%)
[3]
[7] array · 4 items
[0]
>80
[1]
3 (1.96%)
[2]
0 (0.00%)
[3]
[8] array · 4 items
[0]
Gender
[1]
[2]
[3]
0.227
[9] array · 4 items
[0]
Male
[1]
127 (83.01%)
[2]
19 (73.08%)
[3]
[10] array · 4 items
[0]
Female
[1]
26 (16.99%)
[2]
7 (26.92%)
[3]
[11] array · 4 items
[0]
Tobacco use
[1]
[2]
[3]
0.116
[12] array · 4 items
[0]
No
[1]
52 (33.99%)
[2]
13 (50.00%)
[3]
[13] array · 4 items
[0]
Yes
[1]
101 (66.01%)
[2]
13 (50.00%)
[3]
[14] array · 4 items
[0]
Alcohol use
[1]
[2]
[3]
0.301
[15] array · 4 items
[0]
No
[1]
60 (39.22%)
[2]
13 (50.00%)
[3]
[16] array · 4 items
[0]
Yes
[1]
93 (60.78%)
[2]
13 (50.00%)
[3]
[17] array · 4 items
[0]
Arrhythmia
[1]
[2]
[3]
0.903
[18] array · 4 items
[0]
No
[1]
116 (75.82%)
[2]
20 (76.92%)
[3]
[19] array · 4 items
[0]
Yes
[1]
37 (24.18%)
[2]
6 (23.08%)
[3]
[20] array · 4 items
[0]
Pneumonia
[1]
[2]
[3]
0.367
[21] array · 4 items
[0]
No
[1]
139 (90.85%)
[2]
25 (96.15%)
[3]
[22] array · 4 items
[0]
Yes
[1]
14 (9.15%)
[2]
1 (3.85%)
[3]
[23] array · 4 items
[0]
Anastomotic leak
[1]
[2]
[3]
0.286
[24] array · 4 items
[0]
No
[1]
144 (94.12%)
[2]
23 (88.46%)
[3]
[25] array · 4 items
[0]
Yes
[1]
9 (5.88%)
[2]
3 (11.54%)
[3]
[26] array · 4 items
[0]
Adjuvant therapy
[1]
[2]
[3]
0.794
[27] array · 4 items
[0]
No
[1]
49 (32.03%)
[2]
9 (34.62%)
[3]
[28] array · 4 items
[0]
Yes
[1]
104 (67.97%)
[2]
17 (65.38%)
[3]
[29] array · 4 items
[0]
T stage
[1]
[2]
[3]
0.553
[30] array · 4 items
[0]
T1
[1]
10 (6.54%)
[2]
2 (7.69%)
[3]
[31] array · 4 items
[0]
T2
[1]
21 (13.73%)
[2]
6 (23.08%)
[3]
[32] array · 4 items
[0]
T3
[1]
97 (63.40%)
[2]
13 (50.00%)
[3]
[33] array · 4 items
[0]
T4
[1]
25 (16.34%)
[2]
5 (19.23%)
[3]
[34] array · 4 items
[0]
N stage
[1]
[2]
[3]
0.501
[35] array · 4 items
[0]
N0
[1]
70 (45.75%)
[2]
13 (50.00%)
[3]
[36] array · 4 items
[0]
N1
[1]
53 (34.64%)
[2]
9 (34.62%)
[3]
[37] array · 4 items
[0]
N2
[1]
18 (11.76%)
[2]
4 (15.38%)
[3]
[38] array · 4 items
[0]
N3
[1]
12 (7.84%)
[2]
0 (0.00%)
[3]
[39] array · 4 items
[0]
TNM stage
[1]
[2]
[3]
0.809
[40] array · 4 items
[0]
I
[1]
8 (5.23%)
[2]
2 (7.69%)
[3]
[41] array · 4 items
[0]
II
[1]
67 (43.79%)
[2]
10 (38.46%)
[3]
[42] array · 4 items
[0]
III
[1]
78 (50.98%)
[2]
14 (53.85%)
[3]
[43] array · 4 items
[0]
Tumor location
[1]
[2]
[3]
0.142
[44] array · 4 items
[0]
Upper
[1]
19 (12.42%)
[2]
1 (3.85%)
[3]
[45] array · 4 items
[0]
Middle
[1]
85 (55.56%)
[2]
12 (46.15%)
[3]
[46] array · 4 items
[0]
Lower
[1]
49 (32.03%)
[2]
13 (50.00%)
[3]
[47] array · 4 items
[0]
Tumor grade
[1]
[2]
[3]
0.066
[48] array · 4 items
[0]
Well
[1]
31 (20.26%)
[2]
1 (3.85%)
[3]
[49] array · 4 items
[0]
Poorly
[1]
43 (28.10%)
[2]
6 (23.08%)
[3]
[50] array · 4 items
[0]
Moderately
[1]
79 (51.63%)
[2]
19 (73.08%)
[3]
[51] array · 4 items
[0]
Whether death
[1]
[2]
[3]
0.047*
[52] array · 4 items
[0]
No
[1]
67 (43.79%)
[2]
6 (23.08%)
[3]
[53] array · 4 items
[0]
Yes
[1]
86 (56.21%)
[2]
20 (76.92%)
[3]
[54] array · 4 items
[0]
OS
[1]
37.81 ± 23.01
[2]
27.10 ± 20.00
[3]
0.027*
[55] array · 4 items
[0]
Whether recurrence
[1]
[2]
[3]
0.071
[56] array · 4 items
[0]
No
[1]
88 (57.52%)
[2]
10 (38.46%)
[3]
[57] array · 4 items
[0]
Yes
[1]
65 (42.48%)
[2]
16 (61.54%)
[3]
[58] array · 4 items
[0]
RFS
[1]
30.58 ± 25.49
[2]
20.20 ± 21.06
[3]
0.051
locator
section[12]/table-wrap[1]#T1
[4] object · 16 fields
id
asset:table:pmid:32133283:2
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:9743f153f85b1defaef0ff9e1e108499da17d017ea9be74640b9853379bf163f
bytes
2743
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[12]/table-wrap[2]#T2
version
null
note
Association between metabolic syndrome (MetS) and overall survival (OS) in 179 patients in a univariate and multivariable analysis.
structure object · 5 fields
pmcid
PMC7040247
section_index
12
section_title
Mets Is an Independent Prognostic Factor for ESCC
row_count
32
column_count
8
table object · 8 fields
label
Table 2
caption
Association between metabolic syndrome (MetS) and overall survival (OS) in 179 patients in a univariate and multivariable analysis.
rows array · 32 items
[0] array · 8 items
[0]
[1]
[2]
[3]
Univariable
[4]
[5]
[6]
Multivariable
[7]
[1] array · 8 items
[0]
Variable
[1]
[2]
Hazard ratio
[3]
95% confidence interval
[4]
p
[5]
Hazard ratio
[6]
95% confidence interval
[7]
p
[2] array · 8 items
[0]
Age
[1]
<50/50–59
[2]
0.91
[3]
0.46–1.78
[4]
0.776
[5]
0.99
[6]
1.48–2.06
[7]
0.979
[3] array · 8 items
[0]
[1]
60–69/50–59
[2]
1.35
[3]
0.87–2.11
[4]
0.185
[5]
1.41
[6]
0.88–2.35
[7]
0.150
[4] array · 8 items
[0]
[1]
70–79/50–59
[2]
1.91
[3]
1.01–3.61
[4]
0.047*
[5]
2.08
[6]
1.02–4.25
[7]
0.044*
[5] array · 8 items
[0]
[1]
>80/50–59
[2]
5.39
[3]
1.64–17.69
[4]
0.005**
[5]
12.96
[6]
3.62–46.44
[7]
0.0001***
[6] array · 8 items
[0]
Gender
[1]
Female/male
[2]
1.28
[3]
0.80–2.05
[4]
0.306
[5]
–
[6]
–
[7]
–
[7] array · 8 items
[0]
Tobacco use
[1]
Yes/no
[2]
0.75
[3]
0.51–1.10
[4]
0.144
[5]
–
[6]
–
[7]
–
[8] array · 8 items
[0]
Alcohol use
[1]
Yes/no
[2]
0.86
[3]
0.59–1.27
[4]
0.457
[5]
–
[6]
–
[7]
–
[9] array · 8 items
[0]
Adjuvant therapy
[1]
Yes/no
[2]
1.93
[3]
1.22–3.04
[4]
0.004**
[5]
1.24
[6]
0.74–2.10
[7]
0.413
[10] array · 8 items
[0]
T stage
[1]
T1/T3
[2]
0.97
[3]
0.44–2.12
[4]
0.935
[5]
1.40
[6]
0.48–4.08
[7]
0.532
[11] array · 8 items
[0]
[1]
T2/T3
[2]
1.05
[3]
0.60–1.82
[4]
0.870
[5]
1.26
[6]
0.65–2.45
[7]
0.501
[12] array · 8 items
[0]
[1]
T4/T3
[2]
1.64
[3]
1.00–2.67
[4]
0.048*
[5]
1.69
[6]
0.93–3.08
[7]
0.083
[13] array · 8 items
[0]
N stage
[1]
N1/N0
[2]
2.04
[3]
1.31–3.18
[4]
0.001***
[5]
1.37
[6]
0.68–2.75
[7]
0.379
[14] array · 8 items
[0]
[1]
N2/N0
[2]
2.05
[3]
1.14–3.70
[4]
0.017*
[5]
1.20
[6]
0.48–2.97
[7]
0.694
[15] array · 8 items
[0]
[1]
N3/N0
[2]
2.97
[3]
1.42–6.19
[4]
0.003**
[5]
1.74
[6]
0.65–4.64
[7]
0.270
[16] array · 8 items
[0]
TNM stage
[1]
T1/T2
[2]
0.56
[3]
0.17–1.82
[4]
0.336
[5]
0.55
[6]
0.13–2.33
[7]
0.418
[17] array · 8 items
[0]
[1]
T3/T2
[2]
2.03
[3]
1.35–3.06
[4]
0.0006***
[5]
1.68
[6]
0.77–3.68
[7]
0.191
[18] array · 8 items
[0]
Tumor location
[1]
Upper/middle
[2]
1.47
[3]
0.83–2.59
[4]
0.186
[5]
2.03
[6]
1.07–3.86
[7]
0.029*
[19] array · 8 items
[0]
[1]
Lower/middle
[2]
0.88
[3]
0.57–1.35
[4]
0.561
[5]
0.66
[6]
0.41–1.07
[7]
0.088
[20] array · 8 items
[0]
Tumor grade
[1]
Well/moderately
[2]
0.99
[3]
0.57–1.70
[4]
0.961
[5]
1.41
[6]
0.75–2.66
[7]
0.287
[21] array · 8 items
[0]
[1]
Poorly/moderately
[2]
1.63
[3]
1.06–2.50
[4]
0.024*
[5]
1.68
[6]
1.05–2.71
[7]
0.032*
[22] array · 8 items
[0]
MetS
[1]
With/without
[2]
1.73
[3]
1.06–2.82
[4]
0.027*
[5]
2.21
[6]
1.27–3.86
[7]
0.005**
[23] array · 8 items
[0]
BMI
[1]
Yes/no
[2]
1.30
[3]
0.86–1.96
[4]
0.220
[5]
–
[6]
–
[7]
–
[24] array · 8 items
[0]
Hyperglycemia
[1]
Yes/no
[2]
1.24
[3]
0.83–1.83
[4]
0.294
[5]
–
[6]
–
[7]
–
[25] array · 8 items
[0]
Hypertension
[1]
Yes/no
[2]
1.24
[3]
0.83–1.84
[4]
0.290
[5]
–
[6]
–
[7]
–
[26] array · 8 items
[0]
Triglycerides
[1]
Yes/no
[2]
1.11
[3]
0.65–1.89
[4]
0.701
[5]
–
[6]
–
[7]
–
[27] array · 8 items
[0]
HDL-C
[1]
Yes/no
[2]
0.95
[3]
0.59–1.54
[4]
0.848
[5]
–
[6]
–
[7]
–
[28] array · 8 items
[0]
LDL-C
[1]
Yes/no
[2]
1.07
[3]
0.72–1.59
[4]
0.752
[5]
–
[6]
–
[7]
–
[29] array · 8 items
[0]
Arrhythmia
[1]
Yes/no
[2]
1.12
[3]
0.73–1.72
[4]
0.608
[5]
–
[6]
–
[7]
–
[30] array · 8 items
[0]
Pneumonia
[1]
Yes/no
[2]
1.43
[3]
0.72–2.83
[4]
0.309
[5]
–
[6]
–
[7]
–
[31] array · 8 items
[0]
Anastomotic leak
[1]
Yes/no
[2]
1.30
[3]
0.60–2.80
[4]
0.503
[5]
–
[6]
–
[7]
–
locator
section[12]/table-wrap[2]#T2
[5] object · 16 fields
id
asset:table:pmid:32133283:3
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:cb6a34361eaece7d7625d042360cada0a49ac17014d401fc19e6c4b341f29dc9
bytes
2756
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[12]/table-wrap[3]#T3
version
null
note
Association between metabolic syndrome (MetS) and recurrence-free survival (RFS) in 179 patients in a univariate and multivariable analysis.
structure object · 5 fields
pmcid
PMC7040247
section_index
12
section_title
Mets Is an Independent Prognostic Factor for ESCC
row_count
32
column_count
8
table object · 8 fields
label
Table 3
caption
Association between metabolic syndrome (MetS) and recurrence-free survival (RFS) in 179 patients in a univariate and multivariable analysis.
rows array · 32 items
[0] array · 8 items
[0]
[1]
[2]
[3]
Univariable
[4]
[5]
[6]
Multivariable
[7]
[1] array · 8 items
[0]
Variable
[1]
[2]
Hazard ratio
[3]
95% confidence interval
[4]
p
[5]
Hazard ratio
[6]
95% confidence interval
[7]
p
[2] array · 8 items
[0]
Age
[1]
<50/50–59
[2]
1.36
[3]
0.74–2.51
[4]
0.325
[5]
1.83
[6]
0.90–3.70
[7]
0.094
[3] array · 8 items
[0]
[1]
60–69/50–59
[2]
0.75
[3]
0.45–1.26
[4]
0.283
[5]
0.83
[6]
0.46–1.48
[7]
0.525
[4] array · 8 items
[0]
[1]
70–79/50–59
[2]
0.97
[3]
0.43–2.21
[4]
0.947
[5]
1.06
[6]
0.43–2.62
[7]
0.892
[5] array · 8 items
[0]
[1]
>80/50–59
[2]
1.13
[3]
0.15–8.32
[4]
0.901
[5]
2.25
[6]
0.28–17.89
[7]
0.445
[6] array · 8 items
[0]
Gender
[1]
Female/male
[2]
0.75
[3]
0.41–1.39
[4]
0.359
[5]
–
[6]
–
[7]
–
[7] array · 8 items
[0]
Tobacco use
[1]
Yes/no
[2]
1.18
[3]
0.74–1.88
[4]
0.492
[5]
–
[6]
–
[7]
–
[8] array · 8 items
[0]
Alcohol use
[1]
Yes/no
[2]
1.31
[3]
0.83–2.06
[4]
0.247
[5]
–
[6]
–
[7]
–
[9] array · 8 items
[0]
Adjuvant therapy
[1]
Yes/no
[2]
8.50
[3]
3.69–19.55
[4]
0.0001***
[5]
5.34
[6]
2.23–12.77
[7]
0.0002***
[10] array · 8 items
[0]
T stage
[1]
T1/T3
[2]
1.13
[3]
0.48–2.65
[4]
0.776
[5]
1.18
[6]
0.36–3.82
[7]
0.787
[11] array · 8 items
[0]
[1]
T2/T3
[2]
0.80
[3]
0.39–1.64
[4]
0.548
[5]
1.03
[6]
0.44–2.39
[7]
0.946
[12] array · 8 items
[0]
[1]
T4/T3
[2]
2.38
[3]
1.41–4.04
[4]
0.001**
[5]
1.40
[6]
0.74–2.64
[7]
0.303
[13] array · 8 items
[0]
N stage
[1]
N1/N0
[2]
2.51
[3]
1.47–4.29
[4]
0.0001***
[5]
1.03
[6]
0.45–2.35
[7]
0.940
[14] array · 8 items
[0]
[1]
N2/N0
[2]
3.26
[3]
1.67–6.39
[4]
0.0001***
[5]
1.11
[6]
0.41–2.99
[7]
0.833
[15] array · 8 items
[0]
[1]
N3/N0
[2]
6.56
[3]
3.08–14.00
[4]
0.0001***
[5]
2.21
[6]
0.74–6.61
[7]
0.156
[16] array · 8 items
[0]
TNM stage
[1]
T1/T2
[2]
1.15
[3]
0.34–3.89
[4]
0.822
[5]
1.18
[6]
0.28–5.02
[7]
0.824
[17] array · 8 items
[0]
[1]
T3/T2
[2]
3.67
[3]
2.18–6.18
[4]
0.0001***
[5]
2.72
[6]
1.12–6.61
[7]
0.027*
[18] array · 8 items
[0]
Tumor location
[1]
Upper/middle
[2]
1.50
[3]
0.79–2.83
[4]
0.217
[5]
1.37
[6]
0.65–2.86
[7]
0.406
[19] array · 8 items
[0]
[1]
Lower/middle
[2]
0.85
[3]
0.52–1.39
[4]
0.513
[5]
0.58
[6]
0.34–1.00
[7]
0.051
[20] array · 8 items
[0]
Tumor grade
[1]
Well/moderately
[2]
0.76
[3]
0.39–1.46
[4]
0.403
[5]
1.02
[6]
0.47–2.21
[7]
0.959
[21] array · 8 items
[0]
[1]
Poorly/moderately
[2]
1.00
[3]
0.60–1.66
[4]
0.989
[5]
0.86
[6]
0.49–1.51
[7]
0.597
[22] array · 8 items
[0]
MetS
[1]
With/without
[2]
1.71
[3]
0.99–2.96
[4]
0.055
[5]
2.39
[6]
1.29–4.43
[7]
0.005**
[23] array · 8 items
[0]
BMI
[1]
Yes/no
[2]
1.24
[3]
0.77–2.00
[4]
0.373
[5]
–
[6]
–
[7]
–
[24] array · 8 items
[0]
Hyperglycemia
[1]
Yes/no
[2]
1.58
[3]
1.02–2.46
[4]
0.040*
[5]
–
[6]
–
[7]
–
[25] array · 8 items
[0]
Hypertension
[1]
Yes/no
[2]
1.14
[3]
0.72–1.79
[4]
0.574
[5]
–
[6]
–
[7]
–
[26] array · 8 items
[0]
Triglycerides
[1]
Yes/no
[2]
1.04
[3]
0.57–1.93
[4]
0.888
[5]
–
[6]
–
[7]
–
[27] array · 8 items
[0]
HDL-C
[1]
Yes/no
[2]
0.68
[3]
0.38–1.24
[4]
0.211
[5]
–
[6]
–
[7]
–
[28] array · 8 items
[0]
LDL-C
[1]
Yes/no
[2]
0.93
[3]
0.59–1.48
[4]
0.759
[5]
–
[6]
–
[7]
–
[29] array · 8 items
[0]
Arrhythmia
[1]
Yes/no
[2]
0.99
[3]
0.59–1.66
[4]
0.981
[5]
–
[6]
–
[7]
–
[30] array · 8 items
[0]
Pneumonia
[1]
Yes/no
[2]
1.10
[3]
0.48–2.53
[4]
0.821
[5]
–
[6]
–
[7]
–
[31] array · 8 items
[0]
Anastomotic leak
[1]
Yes/no
[2]
1.03
[3]
0.42–2.54
[4]
0.952
[5]
–
[6]
–
[7]
–
locator
section[12]/table-wrap[3]#T3
[6] object · 16 fields
id
asset:table:pmid:32133283:4
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:eb277250bb3200fdfe6eabfe83a81829433accb02c2c9b54229414fc2bbc410d
bytes
1200
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[16]/table-wrap[1]#T4
version
null
note
The multivariable analysis for MetS and six-lncRNA signature.
structure object · 5 fields
pmcid
PMC7040247
section_index
16
section_title
The Six-lncRNA Signature Is an Independent Risk Factor
row_count
11
column_count
8
table object · 8 fields
label
Table 4
caption
The multivariable analysis for MetS and six-lncRNA signature.
rows array · 11 items
[0] array · 4 items
[0]
Group
[1]
Factors
[2]
Overall survival (OS)
[3]
Recurrence-free survival (RFS)
[1] array · 8 items
[0]
[1]
[2]
HR
[3]
95% CI
[4]
p
[5]
HR
[6]
95% CI
[7]
p
[2] array · 8 items
[0]
60 patients(training)
[1]
MetS
[2]
4.26
[3]
1.13–16.03
[4]
0.031*
[5]
5.87
[6]
1.20–28.62
[7]
0.028*
[3] array · 8 items
[0]
[1]
Six-lncRNA signature
[2]
3.49
[3]
1.57–7.77
[4]
0.002**
[5]
5.27
[6]
1.56–17.75
[7]
0.007**
[4] array · 8 items
[0]
59 patients (validation 1)
[1]
MetS
[2]
9.82
[3]
1.96–49.10
[4]
0.005**
[5]
84.26
[6]
5.67–1253.30
[7]
0.001**
[5] array · 8 items
[0]
[1]
Six-lncRNA signature
[2]
7.21
[3]
2.02–25.76
[4]
0.002**
[5]
104.03
[6]
7.90–1370.66
[7]
0.0004***
[6] array · 8 items
[0]
60 patients (validation 2)
[1]
MetS
[2]
2.38
[3]
0.75–7.54
[4]
0.141
[5]
1.32
[6]
0.42–4.16
[7]
0.635
[7] array · 8 items
[0]
[1]
Six-lncRNA signature
[2]
3.00
[3]
1.18–7.62
[4]
0.02*
[5]
3.37
[6]
0.96–11.81
[7]
0.058
[8] array · 8 items
[0]
Total 179 patients
[1]
MetS
[2]
2.67
[3]
1.48–4.83
[4]
0.001**
[5]
2.40
[6]
1.25–4.60
[7]
0.008**
[9] array · 8 items
[0]
[1]
Six-lncRNA signature
[2]
3.97
[3]
2.47–6.36
[4]
0.0001***
[5]
3.23
[6]
1.95–5.35
[7]
0.0001***
[10] array · 8 items
[0]
80 patients from TCGA
[1]
Six-lncRNA signature
[2]
5.37
[3]
1.02–28.41
[4]
0.047*
[5]
3.47
[6]
1.04–11.62
[7]
0.043*
locator
section[16]/table-wrap[1]#T4
gaps array · 4 items
[0]
asset:data:geo:GSE53622 not downloaded
[1]
asset:data:geo:GSE53622 licence not read
[2]
asset:data:geo:GSE53624 not downloaded
[3]
asset:data:geo:GSE53624 licence not read
analysis object · 4 fields
state
complete
methods array · 5 items
[0] object · 10 fields
id
method-1
family
survival_analysis
specific
cox_proportional_hazards
label
Survival analysis
dsl_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
1
band
verbatim
quote
Next, weighted gene co-expression network analysis (WGCNA) was also used to determine the relationship between the module gene and MetS. Significantly correlated module genes were selected using univariate Cox proportional hazards regression (PHR) analysis to calculate the correlation with OS and RFS. The identified lncRNAs with |z| > 2 were selected, and then, multivariate stepwise Cox PHR analysis was used to build a lncRNA predicting model and identify the best risk score cutoff value to distinguish ESCC patients.
[1] object · 10 fields
id
method-2
family
survival_analysis
specific
kaplan_meier
label
Survival analysis
dsl_operations array · 1 item
[0]
survival_km
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.7
band
medium
quote
Kaplan-Meier
[2] object · 10 fields
id
method-3
family
survival_analysis
specific
log_rank_test
label
Survival analysis
dsl_operations array · 1 item
[0]
logrank_test
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.8
band
high
quote
log-rank
[3] object · 10 fields
id
method-4
family
differential_expression
specific
edger
label
Differential expression analysis
dsl_operations array · 3 items
[0]
normalise_counts
[1]
differential_expression_fit
[2]
fdr_bh
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
count_matrix_with_condition
evidence object · 3 fields
score
0.8
band
high
quote
edgeR
[4] object · 10 fields
id
method-5
family
differential_expression
specific
limma_voom
label
Differential expression analysis
dsl_operations array · 3 items
[0]
normalise_counts
[1]
differential_expression_fit
[2]
fdr_bh
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
count_matrix_with_condition
evidence object · 3 fields
score
0.8
band
high
quote
limma
targets array · 0 items
gaps array · 0 items
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
complete
tier
R1
blocked_on
nothing:replicable_now
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
true
required_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: cox_proportional_hazards.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 2 items
[0]
GSE53624
[1]
GSE53622
resolved_accessions array · 2 items
[0]
GSE53624
[1]
GSE53622
statements array · 1 item
[0]
The data that support the findings of this study come from the public free-charged database, and the new clinical information will be available from the corresponding author, without undue reservation, to any qualified researcher.
basis
The paper names GSE53624, GSE53622 in GEO and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 1 item
[0]
cox_ph
assets array · 6 items
[0]
source:pmid:32133283
[1]
data:geo:GSE53622
[2]
asset:table:pmid:32133283:1
[3]
asset:table:pmid:32133283:2
[4]
asset:table:pmid:32133283:3
[5]
asset:table:pmid:32133283:4
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:GSE53622
gaps array · 0 items
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-10-31T18:18:37Z
independence
single_reader
evidence_check object · 2 fields
method
verbatim
availability
verbatim
calls
3
usage object · 3 fields
prompt_tokens
23205
completion_tokens
2162
cached_tokens
784
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:32133283
type
paper
label
pmid:32133283
[1] object · 3 fields
id
source:pmid:32133283
type
manuscript
label
PMID 32133283 full text
[2] object · 3 fields
id
data:geo:GSE53622
type
dataset
label
GEO GSE53622
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:32133283
type
paper
label
pmid:32133283
[1] object · 3 fields
id
source:pmid:32133283
type
manuscript
label
PMID 32133283 full text
[2] object · 3 fields
id
data:geo:GSE53622
type
dataset
label
GEO GSE53622
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-32133283
type
extraction
used array · 1 item
[0]
source:pmid:32133283
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-GSE53622
type
accession_resolution
used array · 1 item
[0]
data:geo:GSE53622
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:32133283
parent_hash
sha256:8522b0ad057e4de5bd4bfab65be07910fd4bbed89ddd2044c4cf270a7c893225
fork_of
null
gaps array · 8 items
[0]
asset:data:geo:GSE53622 licence not read
[1]
asset:data:geo:GSE53622 not downloaded
[2]
asset:data:geo:GSE53624 licence not read
[3]
asset:data:geo:GSE53624 not downloaded
[4]
execution.not_run
[5]
review.human_critique
[6]
review.independent_reader
[7]
review.machine_critique
assays array · 1 item
[0] object · 11 fields
role
analysis
definition_id
survival_analysis
definition_version
f2132e96ae6c7a4e
required_operations array · 1 item
[0]
cox_ph
support_state
supported
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
Next, weighted gene co-expression network analysis (WGCNA) was also used to determine the relationship between the module gene and MetS. Significantly correlated module genes were selected using univariate Cox proportional hazards regression (PHR) analysis to calculate the correlation with OS and RFS. The identified lncRNAs with |z| > 2 were selected, and then, multivariate stepwise Cox PHR analysis was used to build a lncRNA predicting model and identify the best risk score cutoff value to distinguish ESCC patients.
order_basis
analysis_only
id
assay:1
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:32133283", "kind": "science-record", "revision": 7, "content_hash": "sha256:74fdc39d9c4607b0b4c49b671916c346fc5ffed5a1726b8c13a0496bb32b8f8d", "created_at": "2026-11-01T15:40:57Z", "updated_at": "2026-11-01T22:01:21Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "The Prognostic Significance of Metabolic Syndrome and a Related Six-lncRNA Signature in Esophageal Squamous Cell Carcinoma.", "doi": "10.3389/fonc.2020.00061", "pmid": "32133283", "authors": ["Yu Liu", "Liyu Wang", "Hengchang Liu", "Chunxiang Li", "Jie He"], "journal": "Frontiers in oncology", "year": 2020, "abstract": "Background: Metabolic syndrome (MetS) is associated with the development of esophageal squamous cell carcinoma (ESCC), and long non-coding RNAs (lncRNAs) are involved in a variety of mechanisms of MetS and tumor. This study will explore the prognostic effect of MetS and the associated lncRNA signature on ESCC. Methods: Our previous RNA-chip data (GSE53624, GSE53622) for 179 ESCC patients were reanalyzed according to MetS. The recurrence-free survival (RFS) was collected for these patients. The status of the MetS-related tumor microenvironment was analyzed with the CIBERSORT and ESTIMATE algorithms. A lncRNA signature was established with univariate and multivariate Cox proportional hazards regression (PHR) analysis and verified using the Kaplan-Meier survival curve analysis and time-dependent receiver operating characteristic (ROC) curves. A clinical predictive model was constructed based on multiple risk factors, evaluated using C-indexes and calibration curves, and verified using data from the GEO and TCGA databases. Results: The results showed that MetS was an independent risk factor for ESCC patients conferring low OS and RFS. Tumor microenvironment analysis indicated that patients with MetS have high stromal scores and M2 macrophage infiltration. A six-lncRNA signature was established by 60 ESCC patients randomly selected from GSE53624 and identified with an effective predictive ability in validation cohorts (59 patients from GSE53624 and 60 patients from GSE53622), subgroup analysis, and ESCC patients from TCGA. MetS and the six-lncRNA signature could be regarded as independent risk factors and enhanced predictive ability in the clinical predictive model. Conclusions: Our results indicated that MetS was associated with poor prognosis in ESCC patients, and the possible mechanism was related to changes in the tumor microenvironment. MetS and the six-lncRNA signature could also serve as independent risk factors with available clinical application value.", "claims": [{"id": "claim-method", "statement": "Next, weighted gene co-expression network analysis (WGCNA) was also used to determine the relationship between the module gene and MetS. Significantly correlated module genes were selected using univariate Cox proportional hazards regression (PHR) analysis to calculate the correlation with OS and RFS. The identified lncRNAs with |z| > 2 were selected, and then, multivariate stepwise Cox PHR analysis was used to build a lncRNA predicting model and identify the best risk score cutoff value to distinguish ESCC patients.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:32133283", "locator": "sections[6] \"Identification of lncRNA Signature to Predict the Prognosis for ESCC Patients\" paragraph 2", "quote": "Next, weighted gene co-expression network analysis (WGCNA) was also used to determine the relationship between the module gene and MetS. Significantly correlated module genes were selected using univariate Cox proportional hazards regression (PHR) analysis to calculate the correlation with OS and RFS. The identified lncRNAs with |z| > 2 were selected, and then, multivariate stepwise Cox PHR analysis was used to build a lncRNA predicting model and identify the best risk score cutoff value to distinguish ESCC patients."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The data that support the findings of this study come from the public free-charged database, and the new clinical information will be available from the corresponding author, without undue reservation, to any qualified researcher.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:32133283", "locator": "sections[19] \"Data Availability Statement\" paragraph 2", "quote": "The data that support the findings of this study come from the public free-charged database, and the new clinical information will be available from the corresponding author, without undue reservation, to any qualified researcher."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": null, "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:32133283"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE53622"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE53622"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:32133283", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.3389/fonc.2020.00061", "sha256": "sha256:df402d6c0ea0b65d233316e4608f1e59c9a0de6d52c65262536869057abf5567", "bytes": 29836, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.3389/fonc.2020.00061", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC7040247", "source": "europe_pmc_fulltext", "coverage": "whole_body_without_references", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE53622", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE53622", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE53622", "version": null, "note": "The data that support the findings of this study come from the public free-charged database, and the new clinical information will be available from the corresponding author, without undue reservation, to any qualified researcher.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The data that support the findings of this study come from the public free-charged database, and the new clinical information will be available from the corresponding author, without undue reservation, to any qualified researcher.", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM1296956", "GSM1296957", "GSM1296958", "GSM1296959", "GSM1296960", "GSM1296961", "GSM1296962", "GSM1296963", "GSM1296964", "GSM1296965", "GSM1296966", "GSM1296967", "GSM1296968", "GSM1296969", "GSM1296970", "GSM1296971", "GSM1296972", "GSM1296973", "GSM1296974", "GSM1296975", "GSM1296976", "GSM1296977", "GSM1296978", "GSM1296979", "GSM1296980", "GSM1296981", "GSM1296982", "GSM1296983", "GSM1296984", "GSM1296985", "GSM1296986", "GSM1296987", "GSM1296988", "GSM1296989", "GSM1296990", "GSM1296991", "GSM1296992", "GSM1296993", "GSM1296994", "GSM1296995", "GSM1296996", "GSM1296997", "GSM1296998", "GSM1296999", "GSM1297000", "GSM1297001", "GSM1297002", "GSM1297003", "GSM1297004", "GSM1297005", "GSM1297006", "GSM1297007", "GSM1297008", "GSM1297009", "GSM1297010", "GSM1297011", "GSM1297012", "GSM1297013", "GSM1297014", "GSM1297015", "GSM1297016", "GSM1297017", "GSM1297018", "GSM1297019", "GSM1297020", "GSM1297021", "GSM1297022", "GSM1297023", "GSM1297024", "GSM1297025", "GSM1297026", "GSM1297027", "GSM1297028", "GSM1297029", "GSM1297030", "GSM1297031", "GSM1297032", "GSM1297033", "GSM1297034", "GSM1297035", "GSM1297036", "GSM1297037", "GSM1297038", "GSM1297039", "GSM1297040", "GSM1297041", "GSM1297042", "GSM1297043", "GSM1297044", "GSM1297045", "GSM1297046", "GSM1297047", "GSM1297048", "GSM1297049", "GSM1297050", "GSM1297051", "GSM1297052", "GSM1297053", "GSM1297054", "GSM1297055", "GSM1297056", "GSM1297057", "GSM1297058", "GSM1297059", "GSM1297060", "GSM1297061", "GSM1297062", "GSM1297063", "GSM1297064", "GSM1297065", "GSM1297066", "GSM1297067", "GSM1297068", "GSM1297069", "GSM1297070", "GSM1297071", "GSM1297072", "GSM1297073", "GSM1297074", "GSM1297075"], "sample_count": 120, "group_sizes": null, "group_sizes_basis": null, "platform": "18109", "taxon": "Homo sapiens", "title": "LncRNA profile study reveals a three-lncRNA signature associated with the survival of esophageal squamous cell carcinoma patients (independent set)", "resolution_checked_at": "2026-11-01T15:39:54Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "data:geo:GSE53624", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE53624", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE53624", "version": null, "note": "The data that support the findings of this study come from the public free-charged database, and the new clinical information will be available from the corresponding author, without undue reservation, to any qualified researcher.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The data that support the findings of this study come from the public free-charged database, and the new clinical information will be available from the corresponding author, without undue reservation, to any qualified researcher.", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM1297076", "GSM1297077", "GSM1297078", "GSM1297079", "GSM1297080", "GSM1297081", "GSM1297082", "GSM1297083", "GSM1297084", "GSM1297085", "GSM1297086", "GSM1297087", "GSM1297088", "GSM1297089", "GSM1297090", "GSM1297091", "GSM1297092", "GSM1297093", "GSM1297094", "GSM1297095", "GSM1297096", "GSM1297097", "GSM1297098", "GSM1297099", "GSM1297100", "GSM1297101", "GSM1297102", "GSM1297103", "GSM1297104", "GSM1297105", "GSM1297106", "GSM1297107", "GSM1297108", "GSM1297109", "GSM1297110", "GSM1297111", "GSM1297112", "GSM1297113", "GSM1297114", "GSM1297115", "GSM1297116", "GSM1297117", "GSM1297118", "GSM1297119", "GSM1297120", "GSM1297121", "GSM1297122", "GSM1297123", "GSM1297124", "GSM1297125", "GSM1297126", "GSM1297127", "GSM1297128", "GSM1297129", "GSM1297130", "GSM1297131", "GSM1297132", "GSM1297133", "GSM1297134", "GSM1297135", "GSM1297136", "GSM1297137", "GSM1297138", "GSM1297139", "GSM1297140", "GSM1297141", "GSM1297142", "GSM1297143", "GSM1297144", "GSM1297145", "GSM1297146", "GSM1297147", "GSM1297148", "GSM1297149", "GSM1297150", "GSM1297151", "GSM1297152", "GSM1297153", "GSM1297154", "GSM1297155", "GSM1297156", "GSM1297157", "GSM1297158", "GSM1297159", "GSM1297160", "GSM1297161", "GSM1297162", "GSM1297163", "GSM1297164", "GSM1297165", "GSM1297166", "GSM1297167", "GSM1297168", "GSM1297169", "GSM1297170", "GSM1297171", "GSM1297172", "GSM1297173", "GSM1297174", "GSM1297175", "GSM1297176", "GSM1297177", "GSM1297178", "GSM1297179", "GSM1297180", "GSM1297181", "GSM1297182", "GSM1297183", "GSM1297184", "GSM1297185", "GSM1297186", "GSM1297187", "GSM1297188", "GSM1297189", "GSM1297190", "GSM1297191", "GSM1297192", "GSM1297193", "GSM1297194", "GSM1297195", "GSM1297196", "GSM1297197", "GSM1297198", "GSM1297199", "GSM1297200", "GSM1297201", "GSM1297202", "GSM1297203", "GSM1297204", "GSM1297205", "GSM1297206", "GSM1297207", "GSM1297208", "GSM1297209", "GSM1297210", "GSM1297211", "GSM1297212", "GSM1297213", "GSM1297214", "GSM1297215", "GSM1297216", "GSM1297217", "GSM1297218", "GSM1297219", "GSM1297220", "GSM1297221", "GSM1297222", "GSM1297223", "GSM1297224", "GSM1297225", "GSM1297226", "GSM1297227", "GSM1297228", "GSM1297229", "GSM1297230", "GSM1297231", "GSM1297232", "GSM1297233", "GSM1297234", "GSM1297235", "GSM1297236", "GSM1297237", "GSM1297238", "GSM1297239", "GSM1297240", "GSM1297241", "GSM1297242", "GSM1297243", "GSM1297244", "GSM1297245", "GSM1297246", "GSM1297247", "GSM1297248", "GSM1297249", "GSM1297250", "GSM1297251", "GSM1297252", "GSM1297253", "GSM1297254", "GSM1297255", "GSM1297256", "GSM1297257", "GSM1297258", "GSM1297259", "GSM1297260", "GSM1297261", "GSM1297262", "GSM1297263", "GSM1297264", "GSM1297265", "GSM1297266", "GSM1297267", "GSM1297268", "GSM1297269", "GSM1297270", "GSM1297271", "GSM1297272", "GSM1297273", "GSM1297274", "GSM1297275", "GSM1297276", "GSM1297277", "GSM1297278", "GSM1297279", "GSM1297280", "GSM1297281", "GSM1297282", "GSM1297283", "GSM1297284", "GSM1297285", "GSM1297286", "GSM1297287", "GSM1297288", "GSM1297289", "GSM1297290", "GSM1297291", "GSM1297292", "GSM1297293", "GSM1297294", "GSM1297295", "GSM1297296", "GSM1297297", "GSM1297298", "GSM1297299", "GSM1297300", "GSM1297301", "GSM1297302", "GSM1297303", "GSM1297304", "GSM1297305", "GSM1297306", "GSM1297307", "GSM1297308", "GSM1297309", "GSM1297310", "GSM1297311", "GSM1297312", "GSM1297313"], "sample_count": 238, "group_sizes": null, "group_sizes_basis": null, "platform": "18109", "taxon": "Homo sapiens", "title": "LncRNA profile study reveals a three-lncRNA signature associated with the survival of esophageal squamous cell carcinoma patients (original)", "resolution_checked_at": "2026-11-01T15:39:54Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "asset:table:pmid:32133283:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:5c52ee8850452a4f72cab24a45a9c8c9a7cac2a4efc93292f3f45bc0ab484658", "bytes": 2406, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[12]/table-wrap[1]#T1", "version": null, "note": "The clinical characteristics at baseline, stratified by metabolic syndrome (MetS).", "structure": {"pmcid": "PMC7040247", "section_index": 12, "section_title": "Mets Is an Independent Prognostic Factor for ESCC", "row_count": 59, "column_count": 4}, "table": {"label": "Table 1", "caption": "The clinical characteristics at baseline, stratified by metabolic syndrome (MetS).", "rows": [["Variable", "Without MetS", "With MetS", "p value"], ["No. of patients", "153", "26", ""], ["Age", "", "", "0.061"], ["<50", "21 (13.73%)", "2 (7.69%)", ""], ["50–59", "60 (39.22%)", "6 (23.08%)", ""], ["60–69", "58 (37.91%)", "12 (46.15%)", ""], ["70–79", "11 (7.19%)", "6 (23.08%)", ""], [">80", "3 (1.96%)", "0 (0.00%)", ""], ["Gender", "", "", "0.227"], ["Male", "127 (83.01%)", "19 (73.08%)", ""], ["Female", "26 (16.99%)", "7 (26.92%)", ""], ["Tobacco use", "", "", "0.116"], ["No", "52 (33.99%)", "13 (50.00%)", ""], ["Yes", "101 (66.01%)", "13 (50.00%)", ""], ["Alcohol use", "", "", "0.301"], ["No", "60 (39.22%)", "13 (50.00%)", ""], ["Yes", "93 (60.78%)", "13 (50.00%)", ""], ["Arrhythmia", "", "", "0.903"], ["No", "116 (75.82%)", "20 (76.92%)", ""], ["Yes", "37 (24.18%)", "6 (23.08%)", ""], ["Pneumonia", "", "", "0.367"], ["No", "139 (90.85%)", "25 (96.15%)", ""], ["Yes", "14 (9.15%)", "1 (3.85%)", ""], ["Anastomotic leak", "", "", "0.286"], ["No", "144 (94.12%)", "23 (88.46%)", ""], ["Yes", "9 (5.88%)", "3 (11.54%)", ""], ["Adjuvant therapy", "", "", "0.794"], ["No", "49 (32.03%)", "9 (34.62%)", ""], ["Yes", "104 (67.97%)", "17 (65.38%)", ""], ["T stage", "", "", "0.553"], ["T1", "10 (6.54%)", "2 (7.69%)", ""], ["T2", "21 (13.73%)", "6 (23.08%)", ""], ["T3", "97 (63.40%)", "13 (50.00%)", ""], ["T4", "25 (16.34%)", "5 (19.23%)", ""], ["N stage", "", "", "0.501"], ["N0", "70 (45.75%)", "13 (50.00%)", ""], ["N1", "53 (34.64%)", "9 (34.62%)", ""], ["N2", "18 (11.76%)", "4 (15.38%)", ""], ["N3", "12 (7.84%)", "0 (0.00%)", ""], ["TNM stage", "", "", "0.809"], ["I", "8 (5.23%)", "2 (7.69%)", ""], ["II", "67 (43.79%)", "10 (38.46%)", ""], ["III", "78 (50.98%)", "14 (53.85%)", ""], ["Tumor location", "", "", "0.142"], ["Upper", "19 (12.42%)", "1 (3.85%)", ""], ["Middle", "85 (55.56%)", "12 (46.15%)", ""], ["Lower", "49 (32.03%)", "13 (50.00%)", ""], ["Tumor grade", "", "", "0.066"], ["Well", "31 (20.26%)", "1 (3.85%)", ""], ["Poorly", "43 (28.10%)", "6 (23.08%)", ""], ["Moderately", "79 (51.63%)", "19 (73.08%)", ""], ["Whether death", "", "", "0.047*"], ["No", "67 (43.79%)", "6 (23.08%)", ""], ["Yes", "86 (56.21%)", "20 (76.92%)", ""], ["OS", "37.81 ± 23.01", "27.10 ± 20.00", "0.027*"], ["Whether recurrence", "", "", "0.071"], ["No", "88 (57.52%)", "10 (38.46%)", ""], ["Yes", "65 (42.48%)", "16 (61.54%)", ""], ["RFS", "30.58 ± 25.49", "20.20 ± 21.06", "0.051"]], "row_count": 59, "column_count": 4, "numeric_cells": 108, "header_rows": 1, "locator": "section[12]/table-wrap[1]#T1"}}, {"id": "asset:table:pmid:32133283:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:9743f153f85b1defaef0ff9e1e108499da17d017ea9be74640b9853379bf163f", "bytes": 2743, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[12]/table-wrap[2]#T2", "version": null, "note": "Association between metabolic syndrome (MetS) and overall survival (OS) in 179 patients in a univariate and multivariable analysis.", "structure": {"pmcid": "PMC7040247", "section_index": 12, "section_title": "Mets Is an Independent Prognostic Factor for ESCC", "row_count": 32, "column_count": 8}, "table": {"label": "Table 2", "caption": "Association between metabolic syndrome (MetS) and overall survival (OS) in 179 patients in a univariate and multivariable analysis.", "rows": [["", "", "", "Univariable", "", "", "Multivariable", ""], ["Variable", "", "Hazard ratio", "95% confidence interval", "p", "Hazard ratio", "95% confidence interval", "p"], ["Age", "<50/50–59", "0.91", "0.46–1.78", "0.776", "0.99", "1.48–2.06", "0.979"], ["", "60–69/50–59", "1.35", "0.87–2.11", "0.185", "1.41", "0.88–2.35", "0.150"], ["", "70–79/50–59", "1.91", "1.01–3.61", "0.047*", "2.08", "1.02–4.25", "0.044*"], ["", ">80/50–59", "5.39", "1.64–17.69", "0.005**", "12.96", "3.62–46.44", "0.0001***"], ["Gender", "Female/male", "1.28", "0.80–2.05", "0.306", "–", "–", "–"], ["Tobacco use", "Yes/no", "0.75", "0.51–1.10", "0.144", "–", "–", "–"], ["Alcohol use", "Yes/no", "0.86", "0.59–1.27", "0.457", "–", "–", "–"], ["Adjuvant therapy", "Yes/no", "1.93", "1.22–3.04", "0.004**", "1.24", "0.74–2.10", "0.413"], ["T stage", "T1/T3", "0.97", "0.44–2.12", "0.935", "1.40", "0.48–4.08", "0.532"], ["", "T2/T3", "1.05", "0.60–1.82", "0.870", "1.26", "0.65–2.45", "0.501"], ["", "T4/T3", "1.64", "1.00–2.67", "0.048*", "1.69", "0.93–3.08", "0.083"], ["N stage", "N1/N0", "2.04", "1.31–3.18", "0.001***", "1.37", "0.68–2.75", "0.379"], ["", "N2/N0", "2.05", "1.14–3.70", "0.017*", "1.20", "0.48–2.97", "0.694"], ["", "N3/N0", "2.97", "1.42–6.19", "0.003**", "1.74", "0.65–4.64", "0.270"], ["TNM stage", "T1/T2", "0.56", "0.17–1.82", "0.336", "0.55", "0.13–2.33", "0.418"], ["", "T3/T2", "2.03", "1.35–3.06", "0.0006***", "1.68", "0.77–3.68", "0.191"], ["Tumor location", "Upper/middle", "1.47", "0.83–2.59", "0.186", "2.03", "1.07–3.86", "0.029*"], ["", "Lower/middle", "0.88", "0.57–1.35", "0.561", "0.66", "0.41–1.07", "0.088"], ["Tumor grade", "Well/moderately", "0.99", "0.57–1.70", "0.961", "1.41", "0.75–2.66", "0.287"], ["", "Poorly/moderately", "1.63", "1.06–2.50", "0.024*", "1.68", "1.05–2.71", "0.032*"], ["MetS", "With/without", "1.73", "1.06–2.82", "0.027*", "2.21", "1.27–3.86", "0.005**"], ["BMI", "Yes/no", "1.30", "0.86–1.96", "0.220", "–", "–", "–"], ["Hyperglycemia", "Yes/no", "1.24", "0.83–1.83", "0.294", "–", "–", "–"], ["Hypertension", "Yes/no", "1.24", "0.83–1.84", "0.290", "–", "–", "–"], ["Triglycerides", "Yes/no", "1.11", "0.65–1.89", "0.701", "–", "–", "–"], ["HDL-C", "Yes/no", "0.95", "0.59–1.54", "0.848", "–", "–", "–"], ["LDL-C", "Yes/no", "1.07", "0.72–1.59", "0.752", "–", "–", "–"], ["Arrhythmia", "Yes/no", "1.12", "0.73–1.72", "0.608", "–", "–", "–"], ["Pneumonia", "Yes/no", "1.43", "0.72–2.83", "0.309", "–", "–", "–"], ["Anastomotic leak", "Yes/no", "1.30", "0.60–2.80", "0.503", "–", "–", "–"]], "row_count": 32, "column_count": 8, "numeric_cells": 150, "header_rows": 2, "locator": "section[12]/table-wrap[2]#T2"}}, {"id": "asset:table:pmid:32133283:3", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:cb6a34361eaece7d7625d042360cada0a49ac17014d401fc19e6c4b341f29dc9", "bytes": 2756, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[12]/table-wrap[3]#T3", "version": null, "note": "Association between metabolic syndrome (MetS) and recurrence-free survival (RFS) in 179 patients in a univariate and multivariable analysis.", "structure": {"pmcid": "PMC7040247", "section_index": 12, "section_title": "Mets Is an Independent Prognostic Factor for ESCC", "row_count": 32, "column_count": 8}, "table": {"label": "Table 3", "caption": "Association between metabolic syndrome (MetS) and recurrence-free survival (RFS) in 179 patients in a univariate and multivariable analysis.", "rows": [["", "", "", "Univariable", "", "", "Multivariable", ""], ["Variable", "", "Hazard ratio", "95% confidence interval", "p", "Hazard ratio", "95% confidence interval", "p"], ["Age", "<50/50–59", "1.36", "0.74–2.51", "0.325", "1.83", "0.90–3.70", "0.094"], ["", "60–69/50–59", "0.75", "0.45–1.26", "0.283", "0.83", "0.46–1.48", "0.525"], ["", "70–79/50–59", "0.97", "0.43–2.21", "0.947", "1.06", "0.43–2.62", "0.892"], ["", ">80/50–59", "1.13", "0.15–8.32", "0.901", "2.25", "0.28–17.89", "0.445"], ["Gender", "Female/male", "0.75", "0.41–1.39", "0.359", "–", "–", "–"], ["Tobacco use", "Yes/no", "1.18", "0.74–1.88", "0.492", "–", "–", "–"], ["Alcohol use", "Yes/no", "1.31", "0.83–2.06", "0.247", "–", "–", "–"], ["Adjuvant therapy", "Yes/no", "8.50", "3.69–19.55", "0.0001***", "5.34", "2.23–12.77", "0.0002***"], ["T stage", "T1/T3", "1.13", "0.48–2.65", "0.776", "1.18", "0.36–3.82", "0.787"], ["", "T2/T3", "0.80", "0.39–1.64", "0.548", "1.03", "0.44–2.39", "0.946"], ["", "T4/T3", "2.38", "1.41–4.04", "0.001**", "1.40", "0.74–2.64", "0.303"], ["N stage", "N1/N0", "2.51", "1.47–4.29", "0.0001***", "1.03", "0.45–2.35", "0.940"], ["", "N2/N0", "3.26", "1.67–6.39", "0.0001***", "1.11", "0.41–2.99", "0.833"], ["", "N3/N0", "6.56", "3.08–14.00", "0.0001***", "2.21", "0.74–6.61", "0.156"], ["TNM stage", "T1/T2", "1.15", "0.34–3.89", "0.822", "1.18", "0.28–5.02", "0.824"], ["", "T3/T2", "3.67", "2.18–6.18", "0.0001***", "2.72", "1.12–6.61", "0.027*"], ["Tumor location", "Upper/middle", "1.50", "0.79–2.83", "0.217", "1.37", "0.65–2.86", "0.406"], ["", "Lower/middle", "0.85", "0.52–1.39", "0.513", "0.58", "0.34–1.00", "0.051"], ["Tumor grade", "Well/moderately", "0.76", "0.39–1.46", "0.403", "1.02", "0.47–2.21", "0.959"], ["", "Poorly/moderately", "1.00", "0.60–1.66", "0.989", "0.86", "0.49–1.51", "0.597"], ["MetS", "With/without", "1.71", "0.99–2.96", "0.055", "2.39", "1.29–4.43", "0.005**"], ["BMI", "Yes/no", "1.24", "0.77–2.00", "0.373", "–", "–", "–"], ["Hyperglycemia", "Yes/no", "1.58", "1.02–2.46", "0.040*", "–", "–", "–"], ["Hypertension", "Yes/no", "1.14", "0.72–1.79", "0.574", "–", "–", "–"], ["Triglycerides", "Yes/no", "1.04", "0.57–1.93", "0.888", "–", "–", "–"], ["HDL-C", "Yes/no", "0.68", "0.38–1.24", "0.211", "–", "–", "–"], ["LDL-C", "Yes/no", "0.93", "0.59–1.48", "0.759", "–", "–", "–"], ["Arrhythmia", "Yes/no", "0.99", "0.59–1.66", "0.981", "–", "–", "–"], ["Pneumonia", "Yes/no", "1.10", "0.48–2.53", "0.821", "–", "–", "–"], ["Anastomotic leak", "Yes/no", "1.03", "0.42–2.54", "0.952", "–", "–", "–"]], "row_count": 32, "column_count": 8, "numeric_cells": 150, "header_rows": 2, "locator": "section[12]/table-wrap[3]#T3"}}, {"id": "asset:table:pmid:32133283:4", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:eb277250bb3200fdfe6eabfe83a81829433accb02c2c9b54229414fc2bbc410d", "bytes": 1200, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[16]/table-wrap[1]#T4", "version": null, "note": "The multivariable analysis for MetS and six-lncRNA signature.", "structure": {"pmcid": "PMC7040247", "section_index": 16, "section_title": "The Six-lncRNA Signature Is an Independent Risk Factor", "row_count": 11, "column_count": 8}, "table": {"label": "Table 4", "caption": "The multivariable analysis for MetS and six-lncRNA signature.", "rows": [["Group", "Factors", "Overall survival (OS)", "Recurrence-free survival (RFS)"], ["", "", "HR", "95% CI", "p", "HR", "95% CI", "p"], ["60 patients(training)", "MetS", "4.26", "1.13–16.03", "0.031*", "5.87", "1.20–28.62", "0.028*"], ["", "Six-lncRNA signature", "3.49", "1.57–7.77", "0.002**", "5.27", "1.56–17.75", "0.007**"], ["59 patients (validation 1)", "MetS", "9.82", "1.96–49.10", "0.005**", "84.26", "5.67–1253.30", "0.001**"], ["", "Six-lncRNA signature", "7.21", "2.02–25.76", "0.002**", "104.03", "7.90–1370.66", "0.0004***"], ["60 patients (validation 2)", "MetS", "2.38", "0.75–7.54", "0.141", "1.32", "0.42–4.16", "0.635"], ["", "Six-lncRNA signature", "3.00", "1.18–7.62", "0.02*", "3.37", "0.96–11.81", "0.058"], ["Total 179 patients", "MetS", "2.67", "1.48–4.83", "0.001**", "2.40", "1.25–4.60", "0.008**"], ["", "Six-lncRNA signature", "3.97", "2.47–6.36", "0.0001***", "3.23", "1.95–5.35", "0.0001***"], ["80 patients from TCGA", "Six-lncRNA signature", "5.37", "1.02–28.41", "0.047*", "3.47", "1.04–11.62", "0.043*"]], "row_count": 11, "column_count": 8, "numeric_cells": 61, "header_rows": 2, "locator": "section[16]/table-wrap[1]#T4"}}], "gaps": ["asset:data:geo:GSE53622 not downloaded", "asset:data:geo:GSE53622 licence not read", "asset:data:geo:GSE53624 not downloaded", "asset:data:geo:GSE53624 licence not read"]}, "analysis": {"state": "complete", "methods": [{"id": "method-1", "family": "survival_analysis", "specific": "cox_proportional_hazards", "label": "Survival analysis", "dsl_operations": ["cox_ph"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 1.0, "band": "verbatim", "quote": "Next, weighted gene co-expression network analysis (WGCNA) was also used to determine the relationship between the module gene and MetS. Significantly correlated module genes were selected using univariate Cox proportional hazards regression (PHR) analysis to calculate the correlation with OS and RFS. The identified lncRNAs with |z| > 2 were selected, and then, multivariate stepwise Cox PHR analysis was used to build a lncRNA predicting model and identify the best risk score cutoff value to distinguish ESCC patients."}}, {"id": "method-2", "family": "survival_analysis", "specific": "kaplan_meier", "label": "Survival analysis", "dsl_operations": ["survival_km"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.7, "band": "medium", "quote": "Kaplan-Meier"}}, {"id": "method-3", "family": "survival_analysis", "specific": "log_rank_test", "label": "Survival analysis", "dsl_operations": ["logrank_test"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.8, "band": "high", "quote": "log-rank"}}, {"id": "method-4", "family": "differential_expression", "specific": "edger", "label": "Differential expression analysis", "dsl_operations": ["normalise_counts", "differential_expression_fit", "fdr_bh"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["count_matrix_with_condition"], "evidence": {"score": 0.8, "band": "high", "quote": "edgeR"}}, {"id": "method-5", "family": "differential_expression", "specific": "limma_voom", "label": "Differential expression analysis", "dsl_operations": ["normalise_counts", "differential_expression_fit", "fdr_bh"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["count_matrix_with_condition"], "evidence": {"score": 0.8, "band": "high", "quote": "limma"}}], "targets": [], "gaps": []}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["cox_ph"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: cox_proportional_hazards."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE53624", "GSE53622"], "resolved_accessions": ["GSE53624", "GSE53622"], "statements": ["The data that support the findings of this study come from the public free-charged database, and the new clinical information will be available from the corresponding author, without undue reservation, to any qualified researcher."], "basis": "The paper names GSE53624, GSE53622 in GEO and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["cox_ph"], "assets": ["source:pmid:32133283", "data:geo:GSE53622", "asset:table:pmid:32133283:1", "asset:table:pmid:32133283:2", "asset:table:pmid:32133283:3", "asset:table:pmid:32133283:4"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE53622"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:18:37Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 3, "usage": {"prompt_tokens": 23205, "completion_tokens": 2162, "cached_tokens": 784}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:32133283", "type": "paper", "label": "pmid:32133283"}, {"id": "source:pmid:32133283", "type": "manuscript", "label": "PMID 32133283 full text"}, {"id": "data:geo:GSE53622", "type": "dataset", "label": "GEO GSE53622"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:32133283", "type": "paper", "label": "pmid:32133283"}, {"id": "source:pmid:32133283", "type": "manuscript", "label": "PMID 32133283 full text"}, {"id": "data:geo:GSE53622", "type": "dataset", "label": "GEO GSE53622"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-32133283", "type": "extraction", "used": ["source:pmid:32133283"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE53622", "type": "accession_resolution", "used": ["data:geo:GSE53622"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:32133283", "parent_hash": "sha256:8522b0ad057e4de5bd4bfab65be07910fd4bbed89ddd2044c4cf270a7c893225", "fork_of": null, "generation": 6}, "gaps": ["asset:data:geo:GSE53622 licence not read", "asset:data:geo:GSE53622 not downloaded", "asset:data:geo:GSE53624 licence not read", "asset:data:geo:GSE53624 not downloaded", "execution.not_run", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "analysis", "definition_id": "survival_analysis", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["cox_ph"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["Next, weighted gene co-expression network analysis (WGCNA) was also used to determine the relationship between the module gene and MetS. Significantly correlated module genes were selected using univariate Cox proportional hazards regression (PHR) analysis to calculate the correlation with OS and RFS. The identified lncRNAs with |z| > 2 were selected, and then, multivariate stepwise Cox PHR analysis was used to build a lncRNA predicting model and identify the best risk score cutoff value to distinguish ESCC patients."], "order_basis": "analysis_only", "id": "assay:1"}]}